Steele Clarke Smith III

Steele Clarke Smith IIISteele Clarke Smith IIISteele Clarke Smith III
  • Home
  • Story
  • Press
  • Photos
  • Contact
  • More
    • Home
    • Story
    • Press
    • Photos
    • Contact

Steele Clarke Smith III

Steele Clarke Smith IIISteele Clarke Smith IIISteele Clarke Smith III
  • Home
  • Story
  • Press
  • Photos
  • Contact

He Lost Everything: Mario Fields

Surviving Prison & Finding Identity 

When Pain Relief Becomes Dependence: Mario Fields

The Hidden Dangers of Opioids

The Drop In CEO

Steele Clarke Smith III: Driving Innovation in the Medical Cannabis Industry - March 2025

Listen to the Podcast

Endocannabinoid System Challenges Addiction Misconception - June 2025

Read the Article

The Disruptor - Pain Market Dominator - January 2025

Read the Article

A Recovered Life with, Natasha Rester

A Long Road with, Steele Clark Smith III

His Pharmaceutical Company Was Born in a Prison Cell

The AI Edge Podcast

The Disruptor - Pain Market Dominator - January 2019

Government Boot On Neck Of Rx Cannabis - October 2024

Read the Article

Pre-COVID 19 Press

Pre-COVID 19 Press

Pre-COVID 19 Press

Pre-COVID 19 Press

Pre-COVID 19 Press

Pre-COVID 19 Press

DEA Raids Grower 5x - Charles Musgrove

Emerging Medical Marijuana Product in California

Answers That count - Charles musgrove

Emerging Medical Marijuana Product in California

Kassim Osgood - C3 International Inc.

 Charged About Cannabis for Viewing 

Liberty Solutions Reports

Operating a Medical Marijuana Business

Price of Business C3® and Idrasil™ - Steele Clarke Smith III

PR Newswire

"World's Most Dangerous Man" Ken Shamrock Joins C3 International Board of Advisors

02/17/2020

Black Enterprise

Former NFL Player Kassim Osgood Joins the C3 International Board of Advisors

11/01/2019

Convention of States

Convention of States

Florida hosts American Priority Conference, in Miami

10/14/2019

Healthcare Business Today

How Understanding CECD Can Alleviate Anxiety Disorders

02/22/2019

Healthcare Business Today

Ever heard of CECD? Most people haven’t. It stands for Clinical Endocannabinoid Deficiency, and it’s more important to healthcare than people realize. 

11/12/2018

Econo Times

The need for product purity and doctor supervision led C3® International to create Idrasil™, the first prescription-only cannabis tablet. C3 was founded by Steele Clarke Smith III and Theresa Ann Smith, who serve as the company’s Chairman/CEO and President, respectively.

10/26/201

The Pharmaletter

Garden Grove, USA-based cannabis firm C3 International has launched a new product, Idrasil, in the US 

10/09/2019

Chain Drug Review

“Smoking and edible confections can vary greatly from plant to plant and batch to batch, which results in inconsistency and can lead to irregular analgesic or therapeutic results” 

10/04/2018

Inc.com

...another effective way to minimize stress and manage a number of health conditions (including anxiety) is medical marijuana. 

09/26/2018

PRnewsWire.com

Holistic alternative to opiates and narcotics with measurable dosages for the injured, sick and dying

09/17/2018

AlleyWatch

This is a day that would have made Dennis Peron, a historically heroic activist for medical marijuana, jump for joy.

09/2018



Idrasil publishes first white paper on cannabis therapy in over a decade

C3 International Inc., manufacturer of Idrasil™, the first natural cannabis tablet on the market, has published a white paper revisiting the effects of cannabis-based therapy in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions.

August 19, 2014

Global Cancer Consortium

Release: Idrasil, Cannabis in a Pill Founder to exhibit at the Rx for Wealth Symposium April 27 in Huntington Beach.

 April 23, 2013 

Steele Smith Invents Marijuana Pill

Steele Smith Invents Marijuana Pill

Orange County's Leading Source of News, Culture and Entertainment

September 22, 2011

Steele Smith: Prophet of Pot?

Steele Smith Invents Marijuana Pill

Orange County's Leading Source of News, Culture and Entertainment

April 14, 2011

Copyright © 2027 Steele Clarke Smith III  - All Rights Reserved.

Powered by